In this targeted AliveSim format, you will be immersed in two scenarios where you will make clinical decisions managing irAEs and receive dynamic expert mentoring from virtual colleagues until you identify the optimal path.

At the end of the activity, the learner will have completed two hands-on clinical experiences where they learn how to optimally manage irAEs with corrective mentoring from a virtual oncology expert. The design involves two irAE management scenarios that are similar and share the same clinical decision. The optimal choices in the decision will be different in each scenario allowing learners to recognize the optimal management patterns experts use.

Upon completion of the educational activity, participants should be able to:

• Review both common and rare adverse events associated with immune checkpoint inhibitors (ICIs)
• Apply guideline recommended strategies to proactively identify, monitor, and manage immune-related adverse events (irAEs).
• Discuss the importance of the APP role in the collaborative approach for the identification and management of irAEs.